Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exicure, Inc. - Common Stock
(NQ:
XCUR
)
8.440
-3.110 (-26.93%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exicure, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
November 28, 2023
From
Exicure, Inc.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
November 20, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
October 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 18, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 04, 2023
Via
Benzinga
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
August 23, 2023
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
Via
Benzinga
Exicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 11, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
July 14, 2023
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
July 13, 2023
Via
Benzinga
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
May 26, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
May 19, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld
May 04, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
April 27, 2023
From
Exicure, Inc.
Via
Business Wire
3 Nano-Cap Penny Stocks to Buy for Explosive Gains in 2023
April 14, 2023
With the worst of the turbulence behind them, these nano-cap penny stocks are unlikely to remain at such discounted levels for too long.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 05, 2023
Via
Benzinga
Exicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Update
March 27, 2023
From
Exicure, Inc.
Via
Business Wire
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of Directors
February 24, 2023
From
Exicure, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
February 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 28, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 22, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 21, 2022
Via
Benzinga
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
December 21, 2022
Gainers ADC Therapeutics SA (NASDAQ: ADCT) shares rose 36.8% to $4.35 in pre-market trading. ADC Therapeutics and Sobi announced European Commission approval of ZYNLONTA for the treatment of relapsed...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.